Financial

THE LUCUS ADVISORS LLC BUYS NEW STAKE IN ORTHOFIX INTERNATIONAL NV (OFIX)

Lucus Advisors LLC acquired a new position in Orthofix International NV (NASDAQ:OFIX) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 9,299 shares of the medical device company’s stock, valued at approximately $398,000. Lucus Advisors LLC owned about 0.05% of Orthofix International NV at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. KBC Group NV acquired a new position in shares of Orthofix International NV during the third quarter valued at $548,000. Aperio Group LLC boosted its position in shares of Orthofix International NV by 2.6% in the third quarter. Aperio Group LLC now owns 8,952 shares of the medical device company’s stock valued at $383,000 after buying an additional 225 shares during the last quarter. Essex Investment Management Co. LLC acquired a new position in shares of Orthofix International NV during the third quarter valued at $882,000. Old Mutual Global Investors UK Ltd. boosted its position in shares of Orthofix International NV by 250.3% in the third quarter. Old Mutual Global Investors UK Ltd. now owns 9,885 shares of the medical device company’s stock valued at $422,000 after buying an additional 7,063 shares during the last quarter. Finally, Chicago Equity Partners LLC acquired a new position in shares of Orthofix International NV during the third quarter valued at $219,000. 94.94% of the stock is currently owned by institutional investors.

Orthofix International NV (NASDAQ:OFIX) remained flat at $38.13 during midday trading on Thursday. 63,897 shares of the stock were exchanged. Orthofix International NV has a 12 month low of $35.61 and a 12 month high of $48.25. The firm’s 50-day moving average is $38.41 and its 200-day moving average is $42.83. The firm has a market cap of $679.71 million, a price-to-earnings ratio of 72.91 and a beta of 0.45.

 

READ THE REST HERE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button